NCT01128439View on ClinicalTrials.gov

Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Invasive Pneumococcal Disease
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

94612

Kaiser Permanente Vaccine Study Center, Oakland

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

lead

Pfizer

INDUSTRY